Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Bevacizumab). Showing records 1 – 30 of 70 total matches.

[1] [2] [3]

Search Limiters

Last 2 Years | English Only

Levels

Languages

Country

▼ Search Limiters

1. Σινάπης, Χρήστος. Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους.

Degree: 2011, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

The purpose of this study is to describe with great accuracy thepharmacokinetics of intravitreal injection of Avastin in rabbits. Avastin isa very important drug in… (more)

Subjects/Keywords: Φαρμακοκινητική; Ενδοϋαλοειδική ένεση; Avastin; Bevacizumab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Σινάπης, . . (2011). Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/31704

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Σινάπης, Χρήστος. “Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους.” 2011. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 19, 2019. http://hdl.handle.net/10442/hedi/31704.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Σινάπης, Χρήστος. “Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους.” 2011. Web. 19 Apr 2019.

Vancouver:

Σινάπης . Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2011. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10442/hedi/31704.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Σινάπης . Φαρμακοκινητική της ενδοϋαλοειδικής χορήγησης του Avastin (bevacizumab) σε κονίκλους. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2011. Available from: http://hdl.handle.net/10442/hedi/31704

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

2. 김, 종완. 만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과.

Degree: 2016, Ajou University

만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과에 대하여 알아보고자 하였다. 유리체강내 bevacizumab 1.25mg 주입술을 시행 받은 64안의 만성, 비전형적, 재발성 중심성장액맥락망막병증을 대상으로 후향적으로 연구를… (more)

Subjects/Keywords: Bevacizumab; 중심황반두께; 중심성장액맥락망막병증; 시력

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

김, . (2016). 만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과. (Thesis). Ajou University. Retrieved from http://repository.ajou.ac.kr/handle/201003/13058 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022752

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

김, 종완. “만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과.” 2016. Thesis, Ajou University. Accessed April 19, 2019. http://repository.ajou.ac.kr/handle/201003/13058 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022752.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

김, 종완. “만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과.” 2016. Web. 19 Apr 2019.

Vancouver:

김 . 만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과. [Internet] [Thesis]. Ajou University; 2016. [cited 2019 Apr 19]. Available from: http://repository.ajou.ac.kr/handle/201003/13058 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022752.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

김 . 만성, 비전형적, 재발성 중심성장액맥락망막병증에서 유리체강내 bevacizumab 주입술의 효과. [Thesis]. Ajou University; 2016. Available from: http://repository.ajou.ac.kr/handle/201003/13058 ; http://dcoll.ajou.ac.kr:9080/dcollection/jsp/common/DcLoOrgPer.jsp?sItemId=000000022752

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Texas Medical Center

3. Piha-Paul, Sarina A. An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents.

Degree: MS, 2010, Texas Medical Center

 Treatment for cancer often involves combination therapies used both in medical practice and clinical trials. Korn and Simon listed three reasons for the utility of… (more)

Subjects/Keywords: phase I; trial design; bevacizumab. temsirolimus; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Piha-Paul, S. A. (2010). An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents. (Masters Thesis). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/72

Chicago Manual of Style (16th Edition):

Piha-Paul, Sarina A. “An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents.” 2010. Masters Thesis, Texas Medical Center. Accessed April 19, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/72.

MLA Handbook (7th Edition):

Piha-Paul, Sarina A. “An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents.” 2010. Web. 19 Apr 2019.

Vancouver:

Piha-Paul SA. An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents. [Internet] [Masters thesis]. Texas Medical Center; 2010. [cited 2019 Apr 19]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/72.

Council of Science Editors:

Piha-Paul SA. An Innovative Phase I Trial Design Allowing for the Identification of Multiple Potential Maximum Tolerated Doses with Combination Therapy of Targeted Agents. [Masters Thesis]. Texas Medical Center; 2010. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/72

4. Armas Loarte, Guido Simón. Estudio de utilización de medicamentos biológicos ranibizumab y bevacizumab en el servicio de oftalmología del hospital nacional Edgardo Rebagliati Martins de mayo 2011 a mayo 2012.

Degree: 2015, National University of San Marcos

Se analizó la utilización de medicamentos biológicos ranibizumab (2,3mg/0.23mL) y bevacizumab (400mg/16mL) en el Servicio de Oftalmología del Hospital Nacional Edgardo Rebagliati Martins durante el… (more)

Subjects/Keywords: Ranibizumab; Bevacizumab; Agentes antiangiogénicos; Neovascularización coroidea.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Armas Loarte, G. S. (2015). Estudio de utilización de medicamentos biológicos ranibizumab y bevacizumab en el servicio de oftalmología del hospital nacional Edgardo Rebagliati Martins de mayo 2011 a mayo 2012. (Thesis). National University of San Marcos. Retrieved from http://cybertesis.unmsm.edu.pe/handle/cybertesis/4340 ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/2/bitstream ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/1/bitstream

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Armas Loarte, Guido Simón. “Estudio de utilización de medicamentos biológicos ranibizumab y bevacizumab en el servicio de oftalmología del hospital nacional Edgardo Rebagliati Martins de mayo 2011 a mayo 2012.” 2015. Thesis, National University of San Marcos. Accessed April 19, 2019. http://cybertesis.unmsm.edu.pe/handle/cybertesis/4340 ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/2/bitstream ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/1/bitstream.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Armas Loarte, Guido Simón. “Estudio de utilización de medicamentos biológicos ranibizumab y bevacizumab en el servicio de oftalmología del hospital nacional Edgardo Rebagliati Martins de mayo 2011 a mayo 2012.” 2015. Web. 19 Apr 2019.

Vancouver:

Armas Loarte GS. Estudio de utilización de medicamentos biológicos ranibizumab y bevacizumab en el servicio de oftalmología del hospital nacional Edgardo Rebagliati Martins de mayo 2011 a mayo 2012. [Internet] [Thesis]. National University of San Marcos; 2015. [cited 2019 Apr 19]. Available from: http://cybertesis.unmsm.edu.pe/handle/cybertesis/4340 ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/2/bitstream ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/1/bitstream.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Armas Loarte GS. Estudio de utilización de medicamentos biológicos ranibizumab y bevacizumab en el servicio de oftalmología del hospital nacional Edgardo Rebagliati Martins de mayo 2011 a mayo 2012. [Thesis]. National University of San Marcos; 2015. Available from: http://cybertesis.unmsm.edu.pe/handle/cybertesis/4340 ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/2/bitstream ; http://cybertesis.unmsm.edu.pe/bitstream/cybertesis%2F4340/1/bitstream

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Southern California

5. Venkatramani, Rajkumar. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin.

Degree: MS, Preventive Medicine (Health Behavior), 2010, University of Southern California

 Vincristine, irinotecan and temozolomide have been used in various combinations to treat pediatric solid tumors. These combinations, in general have been well tolerated. Outcomes for… (more)

Subjects/Keywords: phase I study; clinical trial; bevacizumab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Venkatramani, R. (2010). A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin. (Masters Thesis). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296

Chicago Manual of Style (16th Edition):

Venkatramani, Rajkumar. “A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin.” 2010. Masters Thesis, University of Southern California. Accessed April 19, 2019. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296.

MLA Handbook (7th Edition):

Venkatramani, Rajkumar. “A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin.” 2010. Web. 19 Apr 2019.

Vancouver:

Venkatramani R. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin. [Internet] [Masters thesis]. University of Southern California; 2010. [cited 2019 Apr 19]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296.

Council of Science Editors:

Venkatramani R. A phase I study of vincristine, escalating doses of irinotecan, temozolomide and bevacizumab (VIT-B) in pediatric and adolescent patients with recurrent or refractory solid tumors of non-hematopoietic origin. [Masters Thesis]. University of Southern California; 2010. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/409812/rec/296

6. Selek, Laurent. Traitement intra-tumoral des gliomes malins par infusion convective de bevacizumab, développement d'un modèle de gliome chez le gros animal, étude anatomique de la diffusion convective dans un encéphale humain. : Intra-tumoral treatment of malignant glioma via convection-enhanced delivery of bevacizumab, development of the first model of glioma in a large animal, anatomical study of convection-enhanced delivery in a human brain.

Degree: Docteur es, BIS - Biotechnologie, instrumentation, signal et imagerie pour la biologie, la médecine et l'environnement, 2016, Grenoble Alpes

 Les gliomes de haut-grades sont des les tumeurs primitives les plus fréquentes du système nerveux central. Le traitement de cette pathologie associe chirurgie, radiothérapie et… (more)

Subjects/Keywords: Gliome; Infusion convective; Anatomie; Bevacizumab; Glioma; Convection enhanced delivery; Anatomy; Bevacizumab; 611

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Selek, L. (2016). Traitement intra-tumoral des gliomes malins par infusion convective de bevacizumab, développement d'un modèle de gliome chez le gros animal, étude anatomique de la diffusion convective dans un encéphale humain. : Intra-tumoral treatment of malignant glioma via convection-enhanced delivery of bevacizumab, development of the first model of glioma in a large animal, anatomical study of convection-enhanced delivery in a human brain. (Doctoral Dissertation). Grenoble Alpes. Retrieved from http://www.theses.fr/2016GREAS040

Chicago Manual of Style (16th Edition):

Selek, Laurent. “Traitement intra-tumoral des gliomes malins par infusion convective de bevacizumab, développement d'un modèle de gliome chez le gros animal, étude anatomique de la diffusion convective dans un encéphale humain. : Intra-tumoral treatment of malignant glioma via convection-enhanced delivery of bevacizumab, development of the first model of glioma in a large animal, anatomical study of convection-enhanced delivery in a human brain.” 2016. Doctoral Dissertation, Grenoble Alpes. Accessed April 19, 2019. http://www.theses.fr/2016GREAS040.

MLA Handbook (7th Edition):

Selek, Laurent. “Traitement intra-tumoral des gliomes malins par infusion convective de bevacizumab, développement d'un modèle de gliome chez le gros animal, étude anatomique de la diffusion convective dans un encéphale humain. : Intra-tumoral treatment of malignant glioma via convection-enhanced delivery of bevacizumab, development of the first model of glioma in a large animal, anatomical study of convection-enhanced delivery in a human brain.” 2016. Web. 19 Apr 2019.

Vancouver:

Selek L. Traitement intra-tumoral des gliomes malins par infusion convective de bevacizumab, développement d'un modèle de gliome chez le gros animal, étude anatomique de la diffusion convective dans un encéphale humain. : Intra-tumoral treatment of malignant glioma via convection-enhanced delivery of bevacizumab, development of the first model of glioma in a large animal, anatomical study of convection-enhanced delivery in a human brain. [Internet] [Doctoral dissertation]. Grenoble Alpes; 2016. [cited 2019 Apr 19]. Available from: http://www.theses.fr/2016GREAS040.

Council of Science Editors:

Selek L. Traitement intra-tumoral des gliomes malins par infusion convective de bevacizumab, développement d'un modèle de gliome chez le gros animal, étude anatomique de la diffusion convective dans un encéphale humain. : Intra-tumoral treatment of malignant glioma via convection-enhanced delivery of bevacizumab, development of the first model of glioma in a large animal, anatomical study of convection-enhanced delivery in a human brain. [Doctoral Dissertation]. Grenoble Alpes; 2016. Available from: http://www.theses.fr/2016GREAS040

7. Tandia, Mahamadou. INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS.

Degree: Docteur es, Sciences pharmacologiques, 2017, Paris Saclay

Le traitement des cancers constitue un problème de santé publique et repose entre autres sur la chirurgie, la radiothérapie, la chimiothérapie, l’hormonothérapie et les thérapies… (more)

Subjects/Keywords: Abcb1; Pharmacocinetique; Pharmacogenetique; Bevacizumab; Sorafenib; Irinotecan; Abcb1; Pharmakinetics; Pharmacogentics; Bevacizumab; Sorafenib; Irinotecan

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tandia, M. (2017). INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS. (Doctoral Dissertation). Paris Saclay. Retrieved from http://www.theses.fr/2017SACLS424

Chicago Manual of Style (16th Edition):

Tandia, Mahamadou. “INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS.” 2017. Doctoral Dissertation, Paris Saclay. Accessed April 19, 2019. http://www.theses.fr/2017SACLS424.

MLA Handbook (7th Edition):

Tandia, Mahamadou. “INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS.” 2017. Web. 19 Apr 2019.

Vancouver:

Tandia M. INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS. [Internet] [Doctoral dissertation]. Paris Saclay; 2017. [cited 2019 Apr 19]. Available from: http://www.theses.fr/2017SACLS424.

Council of Science Editors:

Tandia M. INTERACTIONS ENTRE THERAPIES CIBLEES ANTI-ANGIOGÉNIQUES (BEVACIZUMAB, SORAFÉNIB) ET TRANSPORTEURS D’EFFLUX : INTERACTIONSTARGETED THERAPIES ANTI- ANGIOGENIC(Bevacizumab , SORAFENIB ) AND EFFLUX TRANSPORTERS. [Doctoral Dissertation]. Paris Saclay; 2017. Available from: http://www.theses.fr/2017SACLS424

8. Mazard, Thibault. Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer.

Degree: Docteur es, Cancérologie-Radiothérapie, 2013, Université Montpellier I

Le traitement médical du cancer colorectal a connu ces dernières années d'importantes avancées avec l'arrivée notamment des thérapies ciblées anti-angiogéniques et anti-EGFR. Néanmoins ces molécules… (more)

Subjects/Keywords: Cancer colorectal métastatique; Irinotecan; Bevacizumab; Sorafenib; Abcg2; Densité tumorale; Metastatic colorectal cancer; Irinotecan; Bevacizumab; Sorafenib; Abcg2; Tumoral density

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mazard, T. (2013). Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer. (Doctoral Dissertation). Université Montpellier I. Retrieved from http://www.theses.fr/2013MON1T017

Chicago Manual of Style (16th Edition):

Mazard, Thibault. “Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer.” 2013. Doctoral Dissertation, Université Montpellier I. Accessed April 19, 2019. http://www.theses.fr/2013MON1T017.

MLA Handbook (7th Edition):

Mazard, Thibault. “Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer.” 2013. Web. 19 Apr 2019.

Vancouver:

Mazard T. Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer. [Internet] [Doctoral dissertation]. Université Montpellier I; 2013. [cited 2019 Apr 19]. Available from: http://www.theses.fr/2013MON1T017.

Council of Science Editors:

Mazard T. Impact clinique et biologique des thérapies ciblées en oncologie digestive : application au cancer colorectal métastatique : Clinical and biological impact of targeted therapies in digestive oncology : application in metastatic colorectal cancer. [Doctoral Dissertation]. Université Montpellier I; 2013. Available from: http://www.theses.fr/2013MON1T017


Université de Lorraine

9. Alaoui Lasmaili, Karima El. Caractérisation au moyen d'outils mathématiques des effets vasculaires du bevacizumab à des fins d'optimisation des protocoles thérapeutiques dans le cas des tumeurs cérébrales : Characterization of the vascular effects of Bevacizumab by the means of mathematical tools for the optimization of therapeutic protocols in the case of brain tumors.

Degree: Docteur es, Sciences de la vie et de la santé, 2017, Université de Lorraine

L’objectif principal de ce travail de thèse a été de caractériser les effets de l’anti-VEGF Bevacizumab (Avastin) sur le réseau vasculaire tumoral in vivo, au… (more)

Subjects/Keywords: Angiogenèse; Microscopie intravitale; Outils mathématiques; Bevacizumab; Thérapie Photodynamique; Angiogenesis; Intravital microscopy; Mathematical tools; Bevacizumab; Photodynamic therapy; 616.075 4; 616.994 061

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alaoui Lasmaili, K. E. (2017). Caractérisation au moyen d'outils mathématiques des effets vasculaires du bevacizumab à des fins d'optimisation des protocoles thérapeutiques dans le cas des tumeurs cérébrales : Characterization of the vascular effects of Bevacizumab by the means of mathematical tools for the optimization of therapeutic protocols in the case of brain tumors. (Doctoral Dissertation). Université de Lorraine. Retrieved from http://www.theses.fr/2017LORR0023

Chicago Manual of Style (16th Edition):

Alaoui Lasmaili, Karima El. “Caractérisation au moyen d'outils mathématiques des effets vasculaires du bevacizumab à des fins d'optimisation des protocoles thérapeutiques dans le cas des tumeurs cérébrales : Characterization of the vascular effects of Bevacizumab by the means of mathematical tools for the optimization of therapeutic protocols in the case of brain tumors.” 2017. Doctoral Dissertation, Université de Lorraine. Accessed April 19, 2019. http://www.theses.fr/2017LORR0023.

MLA Handbook (7th Edition):

Alaoui Lasmaili, Karima El. “Caractérisation au moyen d'outils mathématiques des effets vasculaires du bevacizumab à des fins d'optimisation des protocoles thérapeutiques dans le cas des tumeurs cérébrales : Characterization of the vascular effects of Bevacizumab by the means of mathematical tools for the optimization of therapeutic protocols in the case of brain tumors.” 2017. Web. 19 Apr 2019.

Vancouver:

Alaoui Lasmaili KE. Caractérisation au moyen d'outils mathématiques des effets vasculaires du bevacizumab à des fins d'optimisation des protocoles thérapeutiques dans le cas des tumeurs cérébrales : Characterization of the vascular effects of Bevacizumab by the means of mathematical tools for the optimization of therapeutic protocols in the case of brain tumors. [Internet] [Doctoral dissertation]. Université de Lorraine; 2017. [cited 2019 Apr 19]. Available from: http://www.theses.fr/2017LORR0023.

Council of Science Editors:

Alaoui Lasmaili KE. Caractérisation au moyen d'outils mathématiques des effets vasculaires du bevacizumab à des fins d'optimisation des protocoles thérapeutiques dans le cas des tumeurs cérébrales : Characterization of the vascular effects of Bevacizumab by the means of mathematical tools for the optimization of therapeutic protocols in the case of brain tumors. [Doctoral Dissertation]. Université de Lorraine; 2017. Available from: http://www.theses.fr/2017LORR0023

10. Papagiannaki, Chrysanthi. Effet des antiangiogéniques sur les malformations artério-veineuses cérébrales : Effect of antiangiogenic administration on arteriovenous malformations.

Degree: Docteur es, Neurosciences, 2018, Limoges

Les Malformations Artérioveineuses sont des lésions vasculaires évolutives. Elles peuvent avoir des conséquences neurologiques lourdes liées au risque hémorragique élevé qui est leur mode de… (more)

Subjects/Keywords: Malformation artérioveineuse cérébrale; Angiogenèse; Modèle animal; Antiangiogéniques; Bevacizumab; Brain arteriovenous malformation; Angiogenesis; Animal model; Antiangiogenics; Bevacizumab; 616.8

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Papagiannaki, C. (2018). Effet des antiangiogéniques sur les malformations artério-veineuses cérébrales : Effect of antiangiogenic administration on arteriovenous malformations. (Doctoral Dissertation). Limoges. Retrieved from http://www.theses.fr/2018LIMO0065

Chicago Manual of Style (16th Edition):

Papagiannaki, Chrysanthi. “Effet des antiangiogéniques sur les malformations artério-veineuses cérébrales : Effect of antiangiogenic administration on arteriovenous malformations.” 2018. Doctoral Dissertation, Limoges. Accessed April 19, 2019. http://www.theses.fr/2018LIMO0065.

MLA Handbook (7th Edition):

Papagiannaki, Chrysanthi. “Effet des antiangiogéniques sur les malformations artério-veineuses cérébrales : Effect of antiangiogenic administration on arteriovenous malformations.” 2018. Web. 19 Apr 2019.

Vancouver:

Papagiannaki C. Effet des antiangiogéniques sur les malformations artério-veineuses cérébrales : Effect of antiangiogenic administration on arteriovenous malformations. [Internet] [Doctoral dissertation]. Limoges; 2018. [cited 2019 Apr 19]. Available from: http://www.theses.fr/2018LIMO0065.

Council of Science Editors:

Papagiannaki C. Effet des antiangiogéniques sur les malformations artério-veineuses cérébrales : Effect of antiangiogenic administration on arteriovenous malformations. [Doctoral Dissertation]. Limoges; 2018. Available from: http://www.theses.fr/2018LIMO0065


University of Wollongong

11. Cleary, Tommy. Reconstructing vision - undone Science and Anti-VEGF treatment of wet age-related macular degeneration.

Degree: MA- Research, Faculty of Arts, 2012, University of Wollongong

  Age-related Macular Degeneration (AMD) is an eye disease that can leave people over fifty years old with little or no central vision. It can… (more)

Subjects/Keywords: undone science; Avastin; Lucentis; macular degeneration; Anti-VEGF; ranibizumab; bevacizumab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cleary, T. (2012). Reconstructing vision - undone Science and Anti-VEGF treatment of wet age-related macular degeneration. (Masters Thesis). University of Wollongong. Retrieved from 1113 OPTOMETRY AND OPHTHALMOLOGY, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 160808 Sociology and Social Studies of Science and Technology, 2201 APPLIED ETHICS ; http://ro.uow.edu.au/theses/3615

Chicago Manual of Style (16th Edition):

Cleary, Tommy. “Reconstructing vision - undone Science and Anti-VEGF treatment of wet age-related macular degeneration.” 2012. Masters Thesis, University of Wollongong. Accessed April 19, 2019. 1113 OPTOMETRY AND OPHTHALMOLOGY, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 160808 Sociology and Social Studies of Science and Technology, 2201 APPLIED ETHICS ; http://ro.uow.edu.au/theses/3615.

MLA Handbook (7th Edition):

Cleary, Tommy. “Reconstructing vision - undone Science and Anti-VEGF treatment of wet age-related macular degeneration.” 2012. Web. 19 Apr 2019.

Vancouver:

Cleary T. Reconstructing vision - undone Science and Anti-VEGF treatment of wet age-related macular degeneration. [Internet] [Masters thesis]. University of Wollongong; 2012. [cited 2019 Apr 19]. Available from: 1113 OPTOMETRY AND OPHTHALMOLOGY, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 160808 Sociology and Social Studies of Science and Technology, 2201 APPLIED ETHICS ; http://ro.uow.edu.au/theses/3615.

Council of Science Editors:

Cleary T. Reconstructing vision - undone Science and Anti-VEGF treatment of wet age-related macular degeneration. [Masters Thesis]. University of Wollongong; 2012. Available from: 1113 OPTOMETRY AND OPHTHALMOLOGY, 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified, 160808 Sociology and Social Studies of Science and Technology, 2201 APPLIED ETHICS ; http://ro.uow.edu.au/theses/3615


Texas Medical Center

12. Park, Min S. TEMOZOLOMIDE AND BEVACIZUMAB THERAPY IN ADVANCED HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR.

Degree: MS, 2010, Texas Medical Center

 Tumors comprising the spectrum of hemangiopericytoma/ malignant solitary fibrous tumor (HPC/SFT) are thought to arise from fibroblasts and represent a small subset of soft tissue… (more)

Subjects/Keywords: hemangiopericytoma; solitary fibrous tumor; soft tissue sarcoma; temozolomide; bevacizumab; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Park, M. S. (2010). TEMOZOLOMIDE AND BEVACIZUMAB THERAPY IN ADVANCED HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR. (Masters Thesis). Texas Medical Center. Retrieved from http://digitalcommons.library.tmc.edu/utgsbs_dissertations/105

Chicago Manual of Style (16th Edition):

Park, Min S. “TEMOZOLOMIDE AND BEVACIZUMAB THERAPY IN ADVANCED HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR.” 2010. Masters Thesis, Texas Medical Center. Accessed April 19, 2019. http://digitalcommons.library.tmc.edu/utgsbs_dissertations/105.

MLA Handbook (7th Edition):

Park, Min S. “TEMOZOLOMIDE AND BEVACIZUMAB THERAPY IN ADVANCED HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR.” 2010. Web. 19 Apr 2019.

Vancouver:

Park MS. TEMOZOLOMIDE AND BEVACIZUMAB THERAPY IN ADVANCED HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR. [Internet] [Masters thesis]. Texas Medical Center; 2010. [cited 2019 Apr 19]. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/105.

Council of Science Editors:

Park MS. TEMOZOLOMIDE AND BEVACIZUMAB THERAPY IN ADVANCED HEMANGIOPERICYTOMA/ SOLITARY FIBROUS TUMOR. [Masters Thesis]. Texas Medical Center; 2010. Available from: http://digitalcommons.library.tmc.edu/utgsbs_dissertations/105

13. Kapelakis, Ioannis. Προοπτική μελέτη υπερηχογραφικών δεικτών συστολικής και διαστολικής λειτουργίας της αριστερής κοιλίας σε ογκολογικούς ασθενείς οι οποίοι λαμβάνουν συστηματική χορήγηση bevacizumab.

Degree: 2017, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

Abstract Background: Bevacizumab, is an anti-angiogenic agent recently used widely in the treatment of cancer. Limited data support an increase of the thrombotic events in… (more)

Subjects/Keywords: Συστολική και διαστολική λειτουργία; Μπεβασιζουμάμπη; Systolic and diastolic function; Bevacizumab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kapelakis, I. (2017). Προοπτική μελέτη υπερηχογραφικών δεικτών συστολικής και διαστολικής λειτουργίας της αριστερής κοιλίας σε ογκολογικούς ασθενείς οι οποίοι λαμβάνουν συστηματική χορήγηση bevacizumab. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/40761

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kapelakis, Ioannis. “Προοπτική μελέτη υπερηχογραφικών δεικτών συστολικής και διαστολικής λειτουργίας της αριστερής κοιλίας σε ογκολογικούς ασθενείς οι οποίοι λαμβάνουν συστηματική χορήγηση bevacizumab.” 2017. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 19, 2019. http://hdl.handle.net/10442/hedi/40761.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kapelakis, Ioannis. “Προοπτική μελέτη υπερηχογραφικών δεικτών συστολικής και διαστολικής λειτουργίας της αριστερής κοιλίας σε ογκολογικούς ασθενείς οι οποίοι λαμβάνουν συστηματική χορήγηση bevacizumab.” 2017. Web. 19 Apr 2019.

Vancouver:

Kapelakis I. Προοπτική μελέτη υπερηχογραφικών δεικτών συστολικής και διαστολικής λειτουργίας της αριστερής κοιλίας σε ογκολογικούς ασθενείς οι οποίοι λαμβάνουν συστηματική χορήγηση bevacizumab. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2017. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10442/hedi/40761.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kapelakis I. Προοπτική μελέτη υπερηχογραφικών δεικτών συστολικής και διαστολικής λειτουργίας της αριστερής κοιλίας σε ογκολογικούς ασθενείς οι οποίοι λαμβάνουν συστηματική χορήγηση bevacizumab. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2017. Available from: http://hdl.handle.net/10442/hedi/40761

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. Σινάπης, Άγγελος. Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους.

Degree: 2011, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ)

The purpose of this study is to describe with great accuracy the pharmacokinetics of Avastin, in the left eye and serum, after intravitreal injection of… (more)

Subjects/Keywords: Φαρμακοκινητική; Κόνικλοι; Ενδοϋαλοειδική χορήγηση; Pharmacokinetics; Bevacizumab; Avastin; Rabbits; Intravitreal administration

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Σινάπης, . . (2011). Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους. (Thesis). National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Retrieved from http://hdl.handle.net/10442/hedi/31659

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Σινάπης, Άγγελος. “Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους.” 2011. Thesis, National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ). Accessed April 19, 2019. http://hdl.handle.net/10442/hedi/31659.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Σινάπης, Άγγελος. “Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους.” 2011. Web. 19 Apr 2019.

Vancouver:

Σινάπης . Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους. [Internet] [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2011. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10442/hedi/31659.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Σινάπης . Μελέτη της ενδοφλέβιας και ενδοφθάλμιας συγκέντρωσης του Avastin μετά από ενδοϋαλοειδική χορήγηση στον έτερο οφθαλμό: πειραματική μελέτη σε κονίκλους. [Thesis]. National and Kapodistrian University of Athens; Εθνικό και Καποδιστριακό Πανεπιστήμιο Αθηνών (ΕΚΠΑ); 2011. Available from: http://hdl.handle.net/10442/hedi/31659

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Oxford

15. Mehta, Shaveta. Biomarkers of anti-angiogenic therapy in breast cancer.

Degree: PhD, 2014, University of Oxford

 The hunt for biomarkers for anti-VEGF agent bevacizumab is ongoing since last decade with no success. Identifying robust biomarkers for stratifying patients and for monitoring… (more)

Subjects/Keywords: 616.99; Oncology; Medical sciences; bevacizumab; breast cancer; gene expression array

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mehta, S. (2014). Biomarkers of anti-angiogenic therapy in breast cancer. (Doctoral Dissertation). University of Oxford. Retrieved from http://ora.ox.ac.uk/objects/uuid:8b3869e3-fd60-450c-b165-0fe773681613 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.640005

Chicago Manual of Style (16th Edition):

Mehta, Shaveta. “Biomarkers of anti-angiogenic therapy in breast cancer.” 2014. Doctoral Dissertation, University of Oxford. Accessed April 19, 2019. http://ora.ox.ac.uk/objects/uuid:8b3869e3-fd60-450c-b165-0fe773681613 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.640005.

MLA Handbook (7th Edition):

Mehta, Shaveta. “Biomarkers of anti-angiogenic therapy in breast cancer.” 2014. Web. 19 Apr 2019.

Vancouver:

Mehta S. Biomarkers of anti-angiogenic therapy in breast cancer. [Internet] [Doctoral dissertation]. University of Oxford; 2014. [cited 2019 Apr 19]. Available from: http://ora.ox.ac.uk/objects/uuid:8b3869e3-fd60-450c-b165-0fe773681613 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.640005.

Council of Science Editors:

Mehta S. Biomarkers of anti-angiogenic therapy in breast cancer. [Doctoral Dissertation]. University of Oxford; 2014. Available from: http://ora.ox.ac.uk/objects/uuid:8b3869e3-fd60-450c-b165-0fe773681613 ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.640005


University of California – Irvine

16. Nolen, Shantell Cerise. The Effects of Sequential Treatments on Hippocampal Volume in Malignant Glioma Patients.

Degree: Biomedical and Translational Science, 2016, University of California – Irvine

 Objectives: Malignant gliomas (MG) are very aggressive tumors. Patients receive multi-modal therapies such as surgery, radiation and chemotherapy [temozolomide (Temodar or TMZ) followed in many… (more)

Subjects/Keywords: Oncology; Neurosciences; Medicine; bevacizumab; brain tumor; hippocampus; Malignant glioma; radiation; temozolomide

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Nolen, S. C. (2016). The Effects of Sequential Treatments on Hippocampal Volume in Malignant Glioma Patients. (Thesis). University of California – Irvine. Retrieved from http://www.escholarship.org/uc/item/7wn0g02t

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Nolen, Shantell Cerise. “The Effects of Sequential Treatments on Hippocampal Volume in Malignant Glioma Patients.” 2016. Thesis, University of California – Irvine. Accessed April 19, 2019. http://www.escholarship.org/uc/item/7wn0g02t.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Nolen, Shantell Cerise. “The Effects of Sequential Treatments on Hippocampal Volume in Malignant Glioma Patients.” 2016. Web. 19 Apr 2019.

Vancouver:

Nolen SC. The Effects of Sequential Treatments on Hippocampal Volume in Malignant Glioma Patients. [Internet] [Thesis]. University of California – Irvine; 2016. [cited 2019 Apr 19]. Available from: http://www.escholarship.org/uc/item/7wn0g02t.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Nolen SC. The Effects of Sequential Treatments on Hippocampal Volume in Malignant Glioma Patients. [Thesis]. University of California – Irvine; 2016. Available from: http://www.escholarship.org/uc/item/7wn0g02t

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Western Ontario

17. Fischer, Aren. Cost-Effectiveness Of Bevacizumab Concomitant With The Standard Of Therapy For Newly Diagnosed Glioblastoma.

Degree: 2016, University of Western Ontario

 Glioblastoma Multiforme (GBM), a glioma – cancer of the brain’s glial cells – is the most common and deadly malignant primary central nervous system tumor… (more)

Subjects/Keywords: Cost Utility; Bevacizumab; Glioblastoma Multiforme; Cancer; Ontario; Health Economics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Fischer, A. (2016). Cost-Effectiveness Of Bevacizumab Concomitant With The Standard Of Therapy For Newly Diagnosed Glioblastoma. (Thesis). University of Western Ontario. Retrieved from https://ir.lib.uwo.ca/etd/3757

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Fischer, Aren. “Cost-Effectiveness Of Bevacizumab Concomitant With The Standard Of Therapy For Newly Diagnosed Glioblastoma.” 2016. Thesis, University of Western Ontario. Accessed April 19, 2019. https://ir.lib.uwo.ca/etd/3757.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Fischer, Aren. “Cost-Effectiveness Of Bevacizumab Concomitant With The Standard Of Therapy For Newly Diagnosed Glioblastoma.” 2016. Web. 19 Apr 2019.

Vancouver:

Fischer A. Cost-Effectiveness Of Bevacizumab Concomitant With The Standard Of Therapy For Newly Diagnosed Glioblastoma. [Internet] [Thesis]. University of Western Ontario; 2016. [cited 2019 Apr 19]. Available from: https://ir.lib.uwo.ca/etd/3757.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Fischer A. Cost-Effectiveness Of Bevacizumab Concomitant With The Standard Of Therapy For Newly Diagnosed Glioblastoma. [Thesis]. University of Western Ontario; 2016. Available from: https://ir.lib.uwo.ca/etd/3757

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manitoba

18. Mozolevska, Viktoriya. The cardioprotective role of renin-angiotensin system antagonists in the prevention of Bevacizumab and Sunitinib mediated cardiotoxicity.

Degree: Physiology and Pathophysiology, 2016, University of Manitoba

 Background: Targeted agents Bevacizumab and Sunitinib are associated with an increased risk of cardiovascular complications in colorectal and renal cancer settings, respectively. Objective: To elucidate… (more)

Subjects/Keywords: Cardio-oncology; Cardiotoxicity; Bevacizumab; Sunitinib; Heart failure; Renin-angiotensin system

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Mozolevska, V. (2016). The cardioprotective role of renin-angiotensin system antagonists in the prevention of Bevacizumab and Sunitinib mediated cardiotoxicity. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/32419

Chicago Manual of Style (16th Edition):

Mozolevska, Viktoriya. “The cardioprotective role of renin-angiotensin system antagonists in the prevention of Bevacizumab and Sunitinib mediated cardiotoxicity.” 2016. Masters Thesis, University of Manitoba. Accessed April 19, 2019. http://hdl.handle.net/1993/32419.

MLA Handbook (7th Edition):

Mozolevska, Viktoriya. “The cardioprotective role of renin-angiotensin system antagonists in the prevention of Bevacizumab and Sunitinib mediated cardiotoxicity.” 2016. Web. 19 Apr 2019.

Vancouver:

Mozolevska V. The cardioprotective role of renin-angiotensin system antagonists in the prevention of Bevacizumab and Sunitinib mediated cardiotoxicity. [Internet] [Masters thesis]. University of Manitoba; 2016. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/1993/32419.

Council of Science Editors:

Mozolevska V. The cardioprotective role of renin-angiotensin system antagonists in the prevention of Bevacizumab and Sunitinib mediated cardiotoxicity. [Masters Thesis]. University of Manitoba; 2016. Available from: http://hdl.handle.net/1993/32419


University of Debrecen

19. Tóth, Péter. A glioblastoma terápiájának effektivitása és jövőbeli lehetőségek .

Degree: DE – Általános Orvostudományi Kar, University of Debrecen

 A glioblastoma a leggyakoribb primer központi idegrendszeri malignitás felnőttekben. A kórismézésben bevezetésre került az integrált diagnózis fogalma, amely a tumor szövettani jellemzői mellett a molekuláris… (more)

Subjects/Keywords: glioblastoma; temozolomid; bevacizumab; Stupp-protokoll

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tóth, P. (n.d.). A glioblastoma terápiájának effektivitása és jövőbeli lehetőségek . (Thesis). University of Debrecen. Retrieved from http://hdl.handle.net/2437/263473

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Tóth, Péter. “A glioblastoma terápiájának effektivitása és jövőbeli lehetőségek .” Thesis, University of Debrecen. Accessed April 19, 2019. http://hdl.handle.net/2437/263473.

Note: this citation may be lacking information needed for this citation format:
No year of publication.
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Tóth, Péter. “A glioblastoma terápiájának effektivitása és jövőbeli lehetőségek .” Web. 19 Apr 2019.

Note: this citation may be lacking information needed for this citation format:
No year of publication.

Vancouver:

Tóth P. A glioblastoma terápiájának effektivitása és jövőbeli lehetőségek . [Internet] [Thesis]. University of Debrecen; [cited 2019 Apr 19]. Available from: http://hdl.handle.net/2437/263473.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.

Council of Science Editors:

Tóth P. A glioblastoma terápiájának effektivitása és jövőbeli lehetőségek . [Thesis]. University of Debrecen; Available from: http://hdl.handle.net/2437/263473

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation
No year of publication.


University of KwaZulu-Natal

20. Le Roux, Etienne Philip. Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector.

Degree: 2016, University of KwaZulu-Natal

Abstract available in PDF file. Advisors/Committee Members: Kruse, Carl-Heinz. (advisor).

Subjects/Keywords: Bevacizumab.; Neovascular age.; Photodynamic therapy.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Le Roux, E. P. (2016). Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector. (Thesis). University of KwaZulu-Natal. Retrieved from http://hdl.handle.net/10413/16068

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Le Roux, Etienne Philip. “Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector.” 2016. Thesis, University of KwaZulu-Natal. Accessed April 19, 2019. http://hdl.handle.net/10413/16068.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Le Roux, Etienne Philip. “Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector.” 2016. Web. 19 Apr 2019.

Vancouver:

Le Roux EP. Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector. [Internet] [Thesis]. University of KwaZulu-Natal; 2016. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10413/16068.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Le Roux EP. Bevacizumab in a treat-and-extend regimen for neovascular age related macular degeneration in a resource limited sector. [Thesis]. University of KwaZulu-Natal; 2016. Available from: http://hdl.handle.net/10413/16068

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Stellenbosch University

21. Arevalo, J. Fernando. Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy.

Degree: PhD, Medicine, 2018, Stellenbosch University

 ENGLISH ABSTRACT: Bevacizumab is a complete full-length humanized antibody that binds to all subtypes of vascular endothelial growth factor (VEGF) and is used successfully in… (more)

Subjects/Keywords: Bevacizumab; Humanized antibody; Tumors  – Homeopathic treatment; UCTD; Diabetic retinopathy  – Care

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Arevalo, J. F. (2018). Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy. (Doctoral Dissertation). Stellenbosch University. Retrieved from http://hdl.handle.net/10019.1/105095

Chicago Manual of Style (16th Edition):

Arevalo, J Fernando. “Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy.” 2018. Doctoral Dissertation, Stellenbosch University. Accessed April 19, 2019. http://hdl.handle.net/10019.1/105095.

MLA Handbook (7th Edition):

Arevalo, J Fernando. “Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy.” 2018. Web. 19 Apr 2019.

Vancouver:

Arevalo JF. Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy. [Internet] [Doctoral dissertation]. Stellenbosch University; 2018. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10019.1/105095.

Council of Science Editors:

Arevalo JF. Intravitreal Bevacizumab as anti-vascular endothelial growth factor in the management of complications of diabetic retinopathy. [Doctoral Dissertation]. Stellenbosch University; 2018. Available from: http://hdl.handle.net/10019.1/105095

22. Ribeiro, Sabrina Corrêa da Costa. Influência do anticorpo anti-VEGF bevacizumab na inflamação pleural e na pleurodese experimental induzida por talco ou nitrato de prata.

Degree: PhD, Pneumologia, 2011, University of São Paulo

 Introdução: A pleurodese química é rotineiramente utilizada para o controle de derrames pleurais recidivantes. O fator de crescimento do endotélio vascular (VEGF) é uma citocina… (more)

Subjects/Keywords: Angiogenesis inhibitors; Bevacizumab; Bevacizumab; Coelhos; Derrame pleural; Fator de crescimento do endotélio vascular; Inflamação pleural; Inibidores da angiogênese; Pleural effusion; Pleural inflammation; Pleurodese; Pleurodesis; Rabbits; Vascular endothelial growth factor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Ribeiro, S. C. d. C. (2011). Influência do anticorpo anti-VEGF bevacizumab na inflamação pleural e na pleurodese experimental induzida por talco ou nitrato de prata. (Doctoral Dissertation). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/5/5150/tde-27102011-122742/ ;

Chicago Manual of Style (16th Edition):

Ribeiro, Sabrina Corrêa da Costa. “Influência do anticorpo anti-VEGF bevacizumab na inflamação pleural e na pleurodese experimental induzida por talco ou nitrato de prata.” 2011. Doctoral Dissertation, University of São Paulo. Accessed April 19, 2019. http://www.teses.usp.br/teses/disponiveis/5/5150/tde-27102011-122742/ ;.

MLA Handbook (7th Edition):

Ribeiro, Sabrina Corrêa da Costa. “Influência do anticorpo anti-VEGF bevacizumab na inflamação pleural e na pleurodese experimental induzida por talco ou nitrato de prata.” 2011. Web. 19 Apr 2019.

Vancouver:

Ribeiro SCdC. Influência do anticorpo anti-VEGF bevacizumab na inflamação pleural e na pleurodese experimental induzida por talco ou nitrato de prata. [Internet] [Doctoral dissertation]. University of São Paulo; 2011. [cited 2019 Apr 19]. Available from: http://www.teses.usp.br/teses/disponiveis/5/5150/tde-27102011-122742/ ;.

Council of Science Editors:

Ribeiro SCdC. Influência do anticorpo anti-VEGF bevacizumab na inflamação pleural e na pleurodese experimental induzida por talco ou nitrato de prata. [Doctoral Dissertation]. University of São Paulo; 2011. Available from: http://www.teses.usp.br/teses/disponiveis/5/5150/tde-27102011-122742/ ;

23. Barros, Luiz Felipe de Moraes. Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos.

Degree: Mestrado, Clínica Cirúrgica Veterinária, 2006, University of São Paulo

O objetivo do presente trabalho foi avaliar a influência da aplicação de bevacizumab (Avastin®) sobre a angiogênese corneal. Para tanto ratos Wistar, machos, com idade… (more)

Subjects/Keywords: Angiogênese; Angiogenesis; Avastin; Avastin; Bevacizumab; Bevacizumab; Cornea; Córnea; Matrix Metalloproteinases; Metaloproteinases

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Barros, L. F. d. M. (2006). Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos. (Masters Thesis). University of São Paulo. Retrieved from http://www.teses.usp.br/teses/disponiveis/10/10137/tde-13122007-154507/ ;

Chicago Manual of Style (16th Edition):

Barros, Luiz Felipe de Moraes. “Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos.” 2006. Masters Thesis, University of São Paulo. Accessed April 19, 2019. http://www.teses.usp.br/teses/disponiveis/10/10137/tde-13122007-154507/ ;.

MLA Handbook (7th Edition):

Barros, Luiz Felipe de Moraes. “Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos.” 2006. Web. 19 Apr 2019.

Vancouver:

Barros LFdM. Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos. [Internet] [Masters thesis]. University of São Paulo; 2006. [cited 2019 Apr 19]. Available from: http://www.teses.usp.br/teses/disponiveis/10/10137/tde-13122007-154507/ ;.

Council of Science Editors:

Barros LFdM. Efeito da aplicação subconjuntival de Bevacizumab (Avastin®) na angiogênese e na atividade de metaloproteinases em córnea de ratos. [Masters Thesis]. University of São Paulo; 2006. Available from: http://www.teses.usp.br/teses/disponiveis/10/10137/tde-13122007-154507/ ;


University of Utah

24. Welborn, Austin Ray. Simulation of diffusion in three unique situations for the novel capsule drug ring.

Degree: MS;, Mechanical Engineering;, 2010, University of Utah

 This work reports the results of simulations of drug release from a capsule drug ring (CDR) and the diffusion of that drug throughout the eye.… (more)

Subjects/Keywords: Capsule drug ring; Bevacizumab; Avastin; Retinal degeneration; Macular degeneration; Drug release; Drug delivery systems

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Welborn, A. R. (2010). Simulation of diffusion in three unique situations for the novel capsule drug ring. (Masters Thesis). University of Utah. Retrieved from http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/2083/rec/1032

Chicago Manual of Style (16th Edition):

Welborn, Austin Ray. “Simulation of diffusion in three unique situations for the novel capsule drug ring.” 2010. Masters Thesis, University of Utah. Accessed April 19, 2019. http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/2083/rec/1032.

MLA Handbook (7th Edition):

Welborn, Austin Ray. “Simulation of diffusion in three unique situations for the novel capsule drug ring.” 2010. Web. 19 Apr 2019.

Vancouver:

Welborn AR. Simulation of diffusion in three unique situations for the novel capsule drug ring. [Internet] [Masters thesis]. University of Utah; 2010. [cited 2019 Apr 19]. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/2083/rec/1032.

Council of Science Editors:

Welborn AR. Simulation of diffusion in three unique situations for the novel capsule drug ring. [Masters Thesis]. University of Utah; 2010. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd2/id/2083/rec/1032


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

25. Boutsikou, Efimia. Ο ρόλος των βιολογικών παραγόντων στην αντιμετώπιση ασθενών με μη μικροκυτταρικό καρκίνο του πνεύμονα.

Degree: 2014, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

Bevacizumab and Erlotinib have recently been demonstrated to prolong overall survival in patients with non squamous non small-cell lung cancer (NSCLC). We designed a four… (more)

Subjects/Keywords: Μη μικροκυτταρικός καρκίνος πνεύμονα; Βιολογικοί παράγοντες; Ερλοτινίμπη; Μπεβασιζουμάμπη; Lung cancer; Bevacizumab; erlotinib; VEGF; EGFR; NSCLC

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Boutsikou, E. (2014). Ο ρόλος των βιολογικών παραγόντων στην αντιμετώπιση ασθενών με μη μικροκυτταρικό καρκίνο του πνεύμονα. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/34569

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Boutsikou, Efimia. “Ο ρόλος των βιολογικών παραγόντων στην αντιμετώπιση ασθενών με μη μικροκυτταρικό καρκίνο του πνεύμονα.” 2014. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed April 19, 2019. http://hdl.handle.net/10442/hedi/34569.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Boutsikou, Efimia. “Ο ρόλος των βιολογικών παραγόντων στην αντιμετώπιση ασθενών με μη μικροκυτταρικό καρκίνο του πνεύμονα.” 2014. Web. 19 Apr 2019.

Vancouver:

Boutsikou E. Ο ρόλος των βιολογικών παραγόντων στην αντιμετώπιση ασθενών με μη μικροκυτταρικό καρκίνο του πνεύμονα. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2014. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10442/hedi/34569.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Boutsikou E. Ο ρόλος των βιολογικών παραγόντων στην αντιμετώπιση ασθενών με μη μικροκυτταρικό καρκίνο του πνεύμονα. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2014. Available from: http://hdl.handle.net/10442/hedi/34569

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manchester

26. Horsley, Laura. Imaging biomarkers of the tumour microenvironment to assess early response in patients treated with anti-angiogenic therapy.

Degree: PhD, 2015, University of Manchester

 Background: Angiogenesis is the process by which new blood vessels develop from existing vasculature and is a critical step in all tumours to facilitate growth… (more)

Subjects/Keywords: 616.99; biomarker; angiogenesis; imaging; DCE-MRI; DWI-MRI; circulating angiocytokines; clinical trial; bevacizumab

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Horsley, L. (2015). Imaging biomarkers of the tumour microenvironment to assess early response in patients treated with anti-angiogenic therapy. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/imaging-biomarkers-of-the-tumour-microenvironment-to-assess-early-response-in-patients-treated-with-antiangiogenic-therapy(b051dfc5-d3ec-44a7-8fb6-a641626f0f89).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664555

Chicago Manual of Style (16th Edition):

Horsley, Laura. “Imaging biomarkers of the tumour microenvironment to assess early response in patients treated with anti-angiogenic therapy.” 2015. Doctoral Dissertation, University of Manchester. Accessed April 19, 2019. https://www.research.manchester.ac.uk/portal/en/theses/imaging-biomarkers-of-the-tumour-microenvironment-to-assess-early-response-in-patients-treated-with-antiangiogenic-therapy(b051dfc5-d3ec-44a7-8fb6-a641626f0f89).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664555.

MLA Handbook (7th Edition):

Horsley, Laura. “Imaging biomarkers of the tumour microenvironment to assess early response in patients treated with anti-angiogenic therapy.” 2015. Web. 19 Apr 2019.

Vancouver:

Horsley L. Imaging biomarkers of the tumour microenvironment to assess early response in patients treated with anti-angiogenic therapy. [Internet] [Doctoral dissertation]. University of Manchester; 2015. [cited 2019 Apr 19]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/imaging-biomarkers-of-the-tumour-microenvironment-to-assess-early-response-in-patients-treated-with-antiangiogenic-therapy(b051dfc5-d3ec-44a7-8fb6-a641626f0f89).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664555.

Council of Science Editors:

Horsley L. Imaging biomarkers of the tumour microenvironment to assess early response in patients treated with anti-angiogenic therapy. [Doctoral Dissertation]. University of Manchester; 2015. Available from: https://www.research.manchester.ac.uk/portal/en/theses/imaging-biomarkers-of-the-tumour-microenvironment-to-assess-early-response-in-patients-treated-with-antiangiogenic-therapy(b051dfc5-d3ec-44a7-8fb6-a641626f0f89).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.664555


Wayne State University

27. Blocker, Stephanie J. Pet Imaging Of Early Therapeutic Response In Solid Tumors.

Degree: PhD, Cancer Biology, 2017, Wayne State University

  An important pillar of precision medicine for oncology is the ability to identify patients who respond to treatment early into their therapy. Positron emission… (more)

Subjects/Keywords: Bevacizumab; FMAU; Liposome; Positron Emission Tomography (PET); Thymidine; Tumor; Bioimaging and Biomedical Optics; Biology; Oncology

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Blocker, S. J. (2017). Pet Imaging Of Early Therapeutic Response In Solid Tumors. (Doctoral Dissertation). Wayne State University. Retrieved from https://digitalcommons.wayne.edu/oa_dissertations/1785

Chicago Manual of Style (16th Edition):

Blocker, Stephanie J. “Pet Imaging Of Early Therapeutic Response In Solid Tumors.” 2017. Doctoral Dissertation, Wayne State University. Accessed April 19, 2019. https://digitalcommons.wayne.edu/oa_dissertations/1785.

MLA Handbook (7th Edition):

Blocker, Stephanie J. “Pet Imaging Of Early Therapeutic Response In Solid Tumors.” 2017. Web. 19 Apr 2019.

Vancouver:

Blocker SJ. Pet Imaging Of Early Therapeutic Response In Solid Tumors. [Internet] [Doctoral dissertation]. Wayne State University; 2017. [cited 2019 Apr 19]. Available from: https://digitalcommons.wayne.edu/oa_dissertations/1785.

Council of Science Editors:

Blocker SJ. Pet Imaging Of Early Therapeutic Response In Solid Tumors. [Doctoral Dissertation]. Wayne State University; 2017. Available from: https://digitalcommons.wayne.edu/oa_dissertations/1785

28. Πανοηλία, Ειρήνη. Πληθυσμιακή φαρμακοκινητική μοντελοποίηση της μπεβασιζουμάμπης σε ασθενείς με μεταστατικό καρκίνο του παχέος εντέρου.

Degree: 2015, University of Patras

Η ανάγκη εξατομίκευσης της θεραπείας ασθενών που πάσχουν από καρκίνο κρίνεται επιτακτική, λόγω του στενού θεραπευτικού εύρους των αντινεοπλασματικών φαρμάκων και των παρατηρούμενων δια-ατομικών διαφορών… (more)

Subjects/Keywords: Μπεβασιζουμάμπη; Πληθυσμιακή μοντελοποίηση; VEGF πολυμορφισμοί; Ορθοκολικός καρκίνος; Bevacizumab; VEGF; Population modeling; VEGF polymorphisms; Colorectal cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Πανοηλία, . (2015). Πληθυσμιακή φαρμακοκινητική μοντελοποίηση της μπεβασιζουμάμπης σε ασθενείς με μεταστατικό καρκίνο του παχέος εντέρου. (Doctoral Dissertation). University of Patras. Retrieved from http://hdl.handle.net/10889/8628

Chicago Manual of Style (16th Edition):

Πανοηλία, Ειρήνη. “Πληθυσμιακή φαρμακοκινητική μοντελοποίηση της μπεβασιζουμάμπης σε ασθενείς με μεταστατικό καρκίνο του παχέος εντέρου.” 2015. Doctoral Dissertation, University of Patras. Accessed April 19, 2019. http://hdl.handle.net/10889/8628.

MLA Handbook (7th Edition):

Πανοηλία, Ειρήνη. “Πληθυσμιακή φαρμακοκινητική μοντελοποίηση της μπεβασιζουμάμπης σε ασθενείς με μεταστατικό καρκίνο του παχέος εντέρου.” 2015. Web. 19 Apr 2019.

Vancouver:

Πανοηλία . Πληθυσμιακή φαρμακοκινητική μοντελοποίηση της μπεβασιζουμάμπης σε ασθενείς με μεταστατικό καρκίνο του παχέος εντέρου. [Internet] [Doctoral dissertation]. University of Patras; 2015. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10889/8628.

Council of Science Editors:

Πανοηλία . Πληθυσμιακή φαρμακοκινητική μοντελοποίηση της μπεβασιζουμάμπης σε ασθενείς με μεταστατικό καρκίνο του παχέος εντέρου. [Doctoral Dissertation]. University of Patras; 2015. Available from: http://hdl.handle.net/10889/8628

29. Alberola Candel, Vicente. Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab.

Degree: 2018, Karger AG

Subjects/Keywords: Bevacizumab; Cetuximab; Durable remission; Glioma; Medicina

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Alberola Candel, V. (2018). Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab. (Thesis). Karger AG. Retrieved from http://hdl.handle.net/10486/663033

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Alberola Candel, Vicente. “Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab.” 2018. Thesis, Karger AG. Accessed April 19, 2019. http://hdl.handle.net/10486/663033.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Alberola Candel, Vicente. “Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab.” 2018. Web. 19 Apr 2019.

Vancouver:

Alberola Candel V. Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab. [Internet] [Thesis]. Karger AG; 2018. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/10486/663033.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Alberola Candel V. Durable complete remission of a brainstem glioma treated with a combination of bevacizumab and cetuximab. [Thesis]. Karger AG; 2018. Available from: http://hdl.handle.net/10486/663033

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Manitoba

30. Bordun, Kimberly-Ann. Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity.

Degree: Physiology, 2014, University of Manitoba

 Background: Although Bevacizumab (BVZ) and Sunitinib (SNT) prolong survival in cancer patients, an unanticipated side-effect is cardiotoxicity. Early indices of left ventricular (LV) systolic dysfunction… (more)

Subjects/Keywords: Cancer; Cardiomyopathy; Bevacizumab; Sunitinib; Cardiotoxicity; Echocardiography; Tissue velocity imaging; Biomarkers; Hemodynamics; Oxidative stress

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Bordun, K. (2014). Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity. (Masters Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/23884

Chicago Manual of Style (16th Edition):

Bordun, Kimberly-Ann. “Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity.” 2014. Masters Thesis, University of Manitoba. Accessed April 19, 2019. http://hdl.handle.net/1993/23884.

MLA Handbook (7th Edition):

Bordun, Kimberly-Ann. “Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity.” 2014. Web. 19 Apr 2019.

Vancouver:

Bordun K. Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity. [Internet] [Masters thesis]. University of Manitoba; 2014. [cited 2019 Apr 19]. Available from: http://hdl.handle.net/1993/23884.

Council of Science Editors:

Bordun K. Early detection of broken hearts in cancer: Bevacizumab and Sunitinib mediated cardiotoxicity. [Masters Thesis]. University of Manitoba; 2014. Available from: http://hdl.handle.net/1993/23884

[1] [2] [3]

.